title: Can advocates keep congress focused on HIV?
mesh_terms: D019380:Anti-HIV Agents; D002017:Budgets; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D015658:HIV Infections; D006801:Humans; D008119:Lobbying; D010330:Patents as Topic / Q000331:legislation & jurisprudence; D010344:Patient Advocacy / Q000331:legislation & jurisprudence*; D011057:Politics; D014481:United States
chemical_list: D019380:Anti-HIV Agents